Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa Pharmaceutical Investing
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma Pharmaceutical Investing
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology Medical Device Investing
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition Biotech Investing
argenx receives feedback from FDA in end-of-phase 2 meeting for efgartigimod in myasthenia gravis Biotech Investing
Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix Pharmaceutical Investing
VANC Bolsters Hema-Fer Market Presence with Amazon Canada Store Launch and Advertising Approvals Pharmaceutical Investing
BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera Pharmaceutical Investing
